These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11870842)

  • 1. Assessment of a potential tumor-seeking manganese metalloporphyrin contrast agent in a mouse model.
    Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Sugiyama M; Takeda H; Saga T; Nakajima S; Sakata I
    Magn Reson Med; 2002 Mar; 47(3):549-53. PubMed ID: 11870842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice.
    Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Takeda H; Saga T; Nakajima S; Sakata I
    Br J Cancer; 2001 Jun; 84(12):1681-5. PubMed ID: 11401324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor enhancement using Mn-metalloporphyrin in mice: magnetic resonance imaging and histopathologic correlation.
    Nasu H; Takehara Y; Isogai S; Kodaira N; Takeda H; Saga T; Nakajima S; Sakata I; Sakahara H
    J Magn Reson Imaging; 2004 Aug; 20(2):294-9. PubMed ID: 15269956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
    Kuo YT; Chen CY; Liu GC; Wang YM
    PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis.
    Ni Y; Petré C; Miao Y; Yu J; Cresens E; Adriaens P; Bosmans H; Semmler W; Baert AL; Marchal G
    Invest Radiol; 1997 Dec; 32(12):770-9. PubMed ID: 9406018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI.
    Marchal G; Ni Y; Herijgers P; Flameng W; Petré C; Bosmans H; Yu J; Ebert W; Hilger CS; Pfefferer D; Semmler W; Baert AL
    Eur Radiol; 1996; 6(1):2-8. PubMed ID: 8797942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous manganese-mesoporphyrin as a magnetic resonance imaging contrast agent: an experimental model using VX-2 carcinoma in rabbits.
    Robinson DH; Schmiedl UP; Starr FL; Nelson JA; Malek R
    Acad Radiol; 1995 Jan; 2(1):43-9. PubMed ID: 9419523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mn-metalloporphyrin conjugated with Gd-DTPA (Gd-ATN10): tumor enhancement agent for magnetic resonance imaging.
    Matsumura A; Shibata Y; Yamamoto T; Nakagawa K; Yasuda S; Nakajima S; Sakata I; Yoshizawa T; Nose T
    Neurol Med Chir (Tokyo); 1997 Apr; 37(4):327-31. PubMed ID: 9136556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice.
    Furmanski P; Longley C
    Cancer Res; 1988 Aug; 48(16):4604-10. PubMed ID: 3396012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mn[III] uroporphyrin I: a novel metalloporphyrin contrast agent for magnetic resonance imaging.
    McMillan JH; Cox GG; Kimler BF; Spicer JS; Batnitzky S
    Magn Reson Imaging; 1991; 9(4):553-8. PubMed ID: 1779726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice.
    Ogan MD; Revel D; Brasch RC
    Invest Radiol; 1987 Oct; 22(10):822-8. PubMed ID: 3429177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Manganese-based Alternative to Gadolinium: Contrast-enhanced MR Angiography, Excretion, Pharmacokinetics, and Metabolism.
    Gale EM; Wey HY; Ramsay I; Yen YF; Sosnovik DE; Caravan P
    Radiology; 2018 Mar; 286(3):865-872. PubMed ID: 29117483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
    Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MnPcS4: a new MRI contrast enhancing agent for tumor localisation in mice.
    Saini SK; Jena A; Dey J; Sharma AK; Singh R
    Magn Reson Imaging; 1995; 13(7):985-90. PubMed ID: 8583877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanodiamond-Manganese dual mode MRI contrast agents for enhanced liver tumor detection.
    Hou W; Toh TB; Abdullah LN; Yvonne TWZ; Lee KJ; Guenther I; Chow EK
    Nanomedicine; 2017 Apr; 13(3):783-793. PubMed ID: 28003120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synthesis of a D-glucosamine contrast agent, Gd-DTPA-DG, and its application in cancer molecular imaging with MRI.
    Zhang W; Chen Y; Guo DJ; Huang ZW; Cai L; He L
    Eur J Radiol; 2011 Sep; 79(3):369-74. PubMed ID: 21106316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic enhancement features of gadophrin-2 on magnetic resonance imaging: an experimental model of VX2 carcinoma and bacterial abscess in rabbit thigh.
    Ju Lee H; Kim IO; Kim TK; Hyung Kim S; Choi JI; Woo Lee J; Kyung Moon W; Choi BI; Chung Han M; Weinmann HJ; Hyun Chang K
    Invest Radiol; 2002 Dec; 37(12):663-71. PubMed ID: 12446999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice.
    Ye J; Xu YK; Liu X; Lü GS
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):139-43. PubMed ID: 16503514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced high resolution magnetic resonance imaging of pigmented malignant melanoma using Mn-TPPS4 and Gd-DTPA: experimental results.
    Mäurer J; Strauss A; Ebert W; Bauer H; Felix R
    Melanoma Res; 2000 Feb; 10(1):40-6. PubMed ID: 10711639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose Gd-DTPA vs. Bis-Gd-mesoporphyrin for monitoring laser-induced tissue necrosis.
    Bremer C; Bankert J; Filler T; Ebert W; Tombach B; Reimer P
    J Magn Reson Imaging; 2005 Jun; 21(6):801-8. PubMed ID: 15906334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.